cetylpyridinium chloride anhydrous has been researched along with Orphan Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Regev, A; Rood, JE | 1 |
| De Santis, M; Egle Gentile, A; Ferrelli, RM; Taruscio, D | 1 |
| Johannsen, DL; Ravussin, E | 1 |
| Braun, S | 1 |
2 review(s) available for cetylpyridinium chloride anhydrous and Orphan Diseases
| Article | Year |
|---|---|
Health Systems Sustainability and Rare Diseases.
Topics: Delivery of Health Care, Integrated; Health; Health Equity; Health Services Accessibility; Healthcare Disparities; Humans; Program Evaluation; Rare Diseases | 2017 |
The role of mitochondria in health and disease.
Topics: Aging; Diabetes Mellitus, Type 2; Health; Humans; Insulin Resistance; Mitochondria, Muscle; Mitochondrial Myopathies; Oxidative Phosphorylation; Rare Diseases | 2009 |
2 other study(ies) available for cetylpyridinium chloride anhydrous and Orphan Diseases
| Article | Year |
|---|---|
The legacy of the Human Genome Project.
Topics: Computational Biology; Databases, Genetic; Genome-Wide Association Study; Genome, Human; Genomics; Health; Human Genetics; Human Genome Project; Humans; Information Dissemination; Neoplasms; Population Groups; Rare Diseases | 2021 |
[Rare diseases: Innovation laboratories for human health].
Topics: Health; Humans; Laboratories; Organizational Innovation; Rare Diseases; Research; Therapies, Investigational | 2012 |